MMR Vaccine Timing with Cosentyx
Cosentyx (secukinumab), an IL-17 inhibitor for psoriasis, psoriatic arthritis, and ankylosing spondylitis, suppresses immune responses, raising infection risks from live vaccines like MMR (measles, mumps, rubella).[1] Administer MMR before starting Cosentyx to avoid weakened vaccine effectiveness or complications.
Official Guidance on Live Vaccines
Cosentyx prescribing information states: Do not administer live vaccines with Cosentyx. For patients without evidence of chickenpox immunity, consider varicella vaccine before starting treatment. MMR, a live attenuated vaccine, falls under this restriction—avoid during Cosentyx use and for varying periods after discontinuation.[1][2]
Recommended Timing Before Starting Cosentyx
Give MMR at least 4 weeks before the first Cosentyx dose. This interval ensures adequate immune response development. Confirm vaccination status and immunity via serology if needed, especially for adults or those with uncertain history.[1][3]
Waiting Period After Stopping Cosentyx
No live vaccines, including MMR, for at least 4-6 months after the last Cosentyx dose—exact duration depends on patient factors like dose and immune status. Consult an immunologist for personalized timing, as IL-17 blockade effects linger.[1][4]
Why Live Vaccines Pose Risks During Treatment
Cosentyx impairs T-cell function, potentially causing live vaccine viruses to replicate uncontrollably, leading to disseminated infections. Case reports show similar risks with other biologics; measles outbreaks have occurred in immunosuppressed patients.[2][5]
Exceptions or Special Cases
- Catch-up vaccination: Prioritize MMR boosters before Cosentyx if seronegative.
- Pregnancy planning: Women should complete MMR at least 1 month before conception if on or planning Cosentyx, due to combined risks.
- Children: Pediatric guidelines align—vaccinate fully before biologics.[3][6]
Inactivated Vaccine Alternatives
Inactivated vaccines (e.g., Tdap, flu shots) are safe with Cosentyx and recommended annually. No timing restrictions apply.[1]
Sources
[1]: Cosentyx Prescribing Information (Novartis)
[2]: CDC Live Vaccines and Immunosuppressants
[3]: ACIP Adult Immunization Schedule
[4]: IDSA Guidelines on Vaccination in Immunocompromised Hosts
[5]: PubMed: Biologics and Vaccine Safety Review
[6]: AAP Red Book: Biologic Agents